Nyushko prostate nomograms vs Isodose RT

This app is intended to assess the risks of prostate cancer (PC) progression after surgical treatment in patients with localized and locally advanced processes. Based on a comprehensive analysis of pre- and postoperative prognostic factors, this application allows to assess and predict the risks of biochemical progression of the disease and use the result to plan subsequent adjuvant therapy in a cohort of patients with high risk of progression after surgery. Also, using the application, it is possible to predict the probability of lymph node metastases, the probability of extracapsulare extension and the probability of seminal vesicle invasion. For patients: This application does not provide a diagnosis; it only predicts the risk of prostate cancer progression. We do not recommend taking any medications. We are not responsible for the misuse of our application. If you are not a doctor, consult a specialist for interpretation of the results obtained, as well as possible correction of treatment. For specialists (oncologist, urologist): Using this application, you can predict the risk of prostate cancer progression with high accuracy, which will allow you to develop further tactics for managing your patients - the result obtained can be used to prescribe further adjuvant therapy or keep the patient under active supervision. The calculation of nomograms in the application is carried out by monthly subscription!

Isodose RT puts verified organ-at-risk dose constraints in your hand at the point of plan review. It is built for radiation oncologists, medical physicists, dosimetrists, and trainees who need the right limit, for the right structure, with the source to back it up. Every constraint is traced to its published primary. You see the exact structure the limit was validated on, for example whole lung minus GTV or brain minus GTV, along with the toxicity endpoint, the evidence grade, a verbatim source snippet, and a resolvable DOI. No value is shown as approved without a verified reference. WHAT YOU GET • A searchable library of organ-at-risk dose constraints across conventional, SBRT, and SRS, drawn from QUANTEC, HyTEC, TG-101, and other validated sources • Pediatric tolerances from PENTEC, labelled so you always know when a limit is pediatric • NTCP by the Lyman-Kutcher-Burman model and TCP, computed from published parameters, with every assumption shown: formula, alpha beta, dose basis, and the parameter source • EQD2 and BED conversion • A plan checker: enter your achieved doses and see pass or fail against the limits, with the modeled risk where a published curve exists for that organ and endpoint • Delineation atlas figures and plain anatomy for each organ • Favourites and full-text search across organ, synonym, and toxicity WHY CLINICIANS TRUST IT • Each limit names the structure it was validated on, so you are not guessing whole organ against organ minus target • The calculators never hide the math • Sources resolve to a DOI you can open and read FREE AND PREMIUM The free tier covers EQD2, BED, and the core adult conventional constraints. Premium opens the full library across SBRT and SRS, the NTCP and TCP calculators, the plan checker, unlimited favourites, and notifications when guidelines change. IMPORTANT Isodose RT is a reference aid, not a treatment planning system. Always verify against your institutional protocol before any clinical use. Terms of Service: https://webofmedicine.ai/isodose-rt/terms Privacy Policy: https://webofmedicine.ai/isodose-rt/privacy